analytics_image
\
Vantage Market Research

Press Release   -   DNA Sequencing Market to Reach Valuation of USD 12.6 Billion by 2028 – Growth in Prevalence of Cancer and Genetic Disorders Drives the Market

Vantage Market Research | 21 Nov 2022

Biotechnology and Life Sciences

DNA Sequencing Market to Reach Valuation of USD 12.6 Billion by 2028 – Growth in Prevalence of Cancer and Genetic Disorders Drives the Market

image

In terms of revenue, the Global DNA Sequencing Market is expected to reach USD 12.6 Billion by 2028, growing at a CAGR (Compound Annual Growth Rate) of 17.5% from 2022 to 2028.

The future trends in personalized genomics to treat different diseases, genetic disorders, advancements in DNA Sequencing Market procedures, and the growing incidence of cancers and pre-natal & neo-natal disorders contribute significantly to the DNA Sequencing Market.

DNA Sequencing Market has brought a standard change in proteomic and genomic research because it is a highly accurate and high-throughput technology used for several applications such as DNA resequencing, de novo assembly, and whole-genome sequencing (WGS). Therefore, this technology is implemented readily in numerous academic research institutes for research studies.

Key Highlights from Report:

· Among Products, the Consumables segment dominated the DNA Sequencing Market with the highest market share and will continue to lead during the forecast period. This is due to the extensive availability of reagents and kits to supply library construction steps like DNA fragmentation, amplification, enrichment, adapter ligation, and quality control.

· Based on the Technology, the Next-Generation Sequencing segment accounted for the highest CAGR in the coming years. This growth is attributed to the increase in the rate of novel viral diseases and the ongoing research & development activity in DNA Sequencing Market.

· North America holds the largest market share and will likely be the most profitable market in the forecast period. This surge is because of the growth in the adoption of highly developed technologies and encouraging support from the government and associated policies in this region.

Market Dynamics

DNA Sequencing Market has high accuracy and speed, is cost-effective, and the outcome can be derived even from low samples. The DNA Sequencing Market garners extensive increases from its execution in varied applications such as microarray and other global analysis methods. DNA Sequencing Market technologies have been advanced from the 1st generation to the 3rd generation, gaining much traction owing to their features. This will likely fuel the DNA Sequencing Market.

The rapid developments in sequencing technology and bioinformatics enable the identification of DNA variations. These developments also determine variants related to the augmented risk for disease. Furthermore, a high range of genes can be tested in a single diagnostic platform simultaneously with the extensive application of Next-generation Sequencing (NGS) and Whole-genome Sequencing (WGS) that expands the efficacy of DNA Sequencing Market in clinical diagnosis applications. All these factors are likely to propel the market’s growth. Also, in biomarker and cancer segments, the application of DNA Sequencing Market will possibly create profitable prospects for the DNA Sequencing Market in the coming years due to the surging prevalence and incidence of cancer worldwide.

However, the high expenditure of establishing and maintaining a sequencing facility and the need for more skilled professionals might hamper the market growth.

Geographically, {Largest_Region}} market is expected to witness the most extensive market growth with a significant growth rate during the forecast period. The region’s market growth can be attributable to various critical factors like the increasing demand for genome sequencing by well-developed research and healthcare facilities, the surge in need for personalized medicines, and high adoption rates of novel & advanced technology. In addition, the United States is a significant contributor to this regional market owing to the growing funding and support activities of government and non-government bodies. Also, there has been a positive blow to this regional market because of the outbreak of COVID-19. Moreover, the presence of significant market participants, the abundance of academic & research institutes, and the availability of technologically advanced products will contribute to the market’s development in North America.

The Global DNA Sequencing Market is Segmented as follows:

  • Product
    • Instruments
    • Consumables
    • Services
  • Technology
    • Third Generation DNA Sequencing
    • Next-Generation Sequencing
    • Sanger Sequencing
  • Application
    • Clinical Investigation
    • Oncology
    • Forensics & Agri-Genomics
    • Reproductive Health
    • HLA Typing
    • Other Applications
  • End-Use
    • Clinical Research
    • Academic Research
    • Biotechnology & Pharmaceutical Companies
    • Hospitals & Clinics
    • Other End-Uses
  • Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa

List of the Key Players of the Global DNA Sequencing Market is:

[object Object]

The Global DNA Sequencing Market Scope can be Tabulated as below:

Parameter Details
Market Size Provided for Years 2016-2028
Base Year 2021
Historic Years 2016-2020
Forecast Years 2022-2028
Segments Covered
  • Product
    • Instruments
    • Consumables
    • Services
  • Technology
    • Third Generation DNA Sequencing
    • Next-Generation Sequencing
    • Sanger Sequencing
  • Application
    • Clinical Investigation
    • Oncology
    • Forensics & Agri-Genomics
    • Reproductive Health
    • HLA Typing
    • Other Applications
  • End-Use
    • Clinical Research
    • Academic Research
    • Biotechnology & Pharmaceutical Companies
    • Hospitals & Clinics
    • Other End-Uses
  • Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
Region & Counties Covered
  • North America
    • U.S.
    • Canada
    • Mexic
  • Eurpe
    • U.K
    • France
    • Germany
    • Italy
    • Spain
    • Rest Of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Suth Korea
    • South East Asia
    • Rest Of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest Of Latin America
  • Middle East & Africa
    • GCC Cuntries
    • South Africa
    • Rest Of Middle East & Africa
Companies Covered
  • Agilent Technologies
  • Illumina Inc.
  • QIAGEN
  • Perkin Elmer
  • Thermo Fisher Scientific
  • Hoffmann-La Roche Ltd.
  • Macrogen Inc.
  • Bio-Rad Laboratories Inc.
  • Oxford Nanopore Technologies Ltd.
  • Myriad Genetics
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market attractiveness analysis by segments and North America, company market share analysis, and COVID-19 impact analysis

About Vantage Market Research:

We, at Vantage Market Research, provide quantified B2B high quality research on more than 20,000 emerging markets, in turn, helping our clients map out constellation of opportunities for their businesses. We, as a competitive intelligence market research and consulting firm provide end to end solutions to our client enterprises to meet their crucial business objectives. Our clientele base spans across 70% of Global Fortune 500 companies. The company provides high quality data and market research services. The company serves various enterprises and clients in a wide variety of industries. The company offers detailed reports on multiple industries including Chemical Materials and Energy, Food and Beverages, Healthcare Technology, etc. The company’s experienced team of Analysts, Researchers, and Consultants use proprietary data sources and numerous statistical tools and techniques to gather and analyse information.

Biotechnology and Life Sciences

DNA Sequencing Market to Reach Valuation of USD 12.6 Billion by 2028 – Growth in Prevalence of Cancer and Genetic Disorders Drives the Market

21 Nov 2022

Min Read

Historical Data | Base Year 
star icon

Access Full Report

DNA Sequencing Market to Reach Valuation of USD 12.6 Billion by 2028 – Growth in Prevalence of Cancer and Genetic Disorders Drives the Market

This report by Vantage Market Research delivers comprehensive analysis of Somatostatin Analogs Market , focusing on Market Size, Share & Trends Analysis Report by Type (Octreotide, Lanreotide, Pasireotide) by Application (Acromegaly, Neuroendocrine Tumors (NETs), Others) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa)

Request Sample
vantage logo

Vantage Market Research & Consultancy Services is all about providing accurate and reliable market intelligence to its clients for the seamless execution of their business growth strategies.

© 2025 Vantage Market Research. All right reserved
Secured Bysecured by
Dna Sequencing Market Size, Share, Growth | Report, 2035